Cutler Group LP Kamada LTD Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$4.42 - $5.43 $20,539 - $25,233	-4,647 Reduced 92.28%	389 $1,000
Q2 2022 Aug 04, 2022	SELL	$4.22 - $5.85 $6,270 - $8,693	-1,486 Reduced 22.78%	5,036 $22,000
Q1 2022 Apr 14, 2022	SELL	$5.43 - $6.81 $33,644 - $42,194	-6,196 Reduced 48.72%	6,522 $36,000
Q4 2021 Jan 18, 2022	SELL	$5.21 - $6.82 $56,304 - $73,703	-10,807 Reduced 45.94%	12,718 $83,000
Q3 2021 Oct 26, 2021	BUY	$5.25 - $5.87 $74,025 - $82,767	14,100 Added 149.6%	23,525 $124,000
Q2 2021 Jul 19, 2021	BUY	$5.67 - $6.33 $53,439 - $59,660	9,425 New	9,425 $54,000

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $332M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.